ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
27.19
+0.56 (2.10%)
Dec 26, 2024, 11:50 AM EST - Market open
ArriVent BioPharma Employees
ArriVent BioPharma had 40 employees as of December 31, 2023.
Employees
40
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,026,200
Market Cap
916.23M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 40 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| The Pennant Group | 5,791 |
| AMN Healthcare Services | 3,585 |
| Phibro Animal Health | 1,940 |
| Pacira BioSciences | 712 |
| AbCellera Biologics | 586 |
| Poseida Therapeutics | 330 |
| Cogent Biosciences | 164 |
| 89bio | 70 |
AVBP News
- 3 months ago - ArriVent Announces Positive Proof-Of-Concept Global Phase 1b Interim Data for Firmonertinib Monotherapy In First-Line EGFR PACC Mutant Non-Small Cell Lung Cancer At The 2024 World Conference On Lung Cancer - GlobeNewsWire
- 4 months ago - Aarvik Therapeutics Announces Option Exercise by Collaboration Partner ArriVent BioPharma - Business Wire
- 4 months ago - ArriVent BioPharma Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - ArriVent to Present Proof-Of-Concept Phase 1b Data for Firmonertinib in EGFR PACC Mutant Non-Small Cell Lung Cancer at the 2024 World Conference on Lung Cancer - GlobeNewsWire
- 7 months ago - ArriVent Announces a Multi-Target ADC Collaboration with Alphamab - GlobeNewsWire
- 7 months ago - ArriVent Appoints John Hohneker, M.D., to its Board of Directors - GlobeNewsWire
- 8 months ago - ArriVent BioPharma Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 8 months ago - ArriVent Appoints Kristine Peterson to its Board of Directors - GlobeNewsWire